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Abstract
Background: Considering the chronic and debilitating nature of HIV infection, health-related quality of life (HRQoL)
is an important patient-reported clinical outcome to better understand the effects of this infection and its treatment
on patients’ lives. The purpose of this study was to assess the HRQoL and its association with sociodemographic,
behavioural, clinical, nutrition-related factors and social support in an Irish HIV cohort.
Methods: A cross-sectional, prospective study using the Medical Outcomes Study HIV Health survey assessed the 10
dimensions of HRQoL and summarised as Physical Health Summary (PHS) and Mental Health Summary (MHS) scores.
Participants were categorised as having good or poor PHS and MHS using the standardised mean score of 50. The
variables independently associated with PHS and MHS were identified using multivariable logistic regression models.
Results: Overall, 521 participants completed the HRQoL questionnaire. The median (IQR) PHS and MHS scores
were 56 (47–60) and 51 (41–58) respectively. All the covariate groups had lower MHS than PHS. Participants with
symptoms of HIV reported the lowest median (IQR) PHS score 44.7 (32.–54.5) and MHS score 36.1 (28.6–48.4).
Of the 10 dimensions of HRQoL, the lowest scores were for the energy level and general health. Symptoms of HIV,
co-morbidities, social support, employment and ethnicity had independent association with both PHS and MHS.
Gender, education, alcohol intake and HIV-complications were associated with PHS. Age, illicit drugs, BMI and
malnutrition were associated with MHS. However, CD4 count and viral load were not independently associated
with PHS and MHS in multivariable regression models.
Conclusion: Overall, HIV-infected people in this cohort had an average level of HRQoL. However, it is impaired in
people with symptoms and co-morbidities, and not independently associated with CD4 and viral load. Alleviating
HIV symptoms and preventing co-morbidities are important in managing HIV. Providing psychosocial supports for
behaviour modification and return to work or exploring new opportunities will help to improve HRQoL. Healthcare
providers and policy makers need to plan and implement programs to routinely assess the HRQoL in a systematic
method to facilitate a holistic management of HIV.
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Background
Advances in the management of HIV have resulted in
significant improvement in the mortality and morbidity
of people living with this infection [1, 2]. As people live
longer, their quality of life (QoL) can be adversely af-
fected by the disease progression, issues associated with
antiretroviral therapy (ART) and the ageing process [3].
Hence, the ongoing management of HIV aims to im-
prove their physical and psychological well-being and
thus health-related quality of life (HRQoL) [1]. In rou-
tine clinical practices, assessments of HIV treatment
outcomes are usually focussed on the objective clinical
parameters including quantification of plasma viral load
and CD4 level. However, they reflect the pathological ab-
normalities related to this disease, but not its effects on
QoL [4].
QoL is a multifactorial and multidimensional concept
of physical, psychological, and social functioning and
well-being, and the impact of a disease and treatment on
QoL is referred as HRQoL [5–7]. It is important to as-
sess the HRQoL as a treatment outcome in HIV man-
agement as it reflects the patients’ experiences of living
with this chronic condition. At the same time, the im-
pact of the factors directly or indirectly related to HIV
infection need to be considered due to potential con-
founding effects of these factors on HRQoL. Also,
HRQoL is a subjective concept which is dynamic in
terms of person, place and time [8, 9]. Hence, assessing
the HRQoL of people living with HIV in different coun-
tries is beneficial to compare and better understand the
treatment outcomes of this global epidemic condition.
Several previous studies have assessed the HRQoL of
people with HIV in different countries. These reports
vary in terms of its effects on different dimensions of life
and the associated factors [10–19]. The negative effects
of HIV on QoL have been reported by many studies [17,
18, 20–23]. On the other hand, one study showed im-
provement in QoL and they reported this as a result of
lifestyle modification after diagnosing HIV [19]. Consid-
ering the multifactorial aspect of HRQoL, various studies
explored its association with sociodemographic factors,
clinical factors, behavioural factors and social support
[12, 15, 24–27]. Having symptoms of HIV and co-
morbidities, illicit drug use, unemployment and lack of
social support were consistently reported to have adverse
effects on HRQoL [22, 28–32]. However, reports about
the association of age, gender, ethnicity, and ART with
HRQoL are inconsistent [3, 12, 22, 24, 26, 27, 29, 33–
37]. This may be due to the discrepancies in the research
methodologies used in those studies.
Many previous studies have reported separately on the
impact of sociodemographic, behavioural and clinical
factors and social support on HRQoL, and only few
studies addressed the impact of these factors combined.
Also, very little is known about the effects of nutritional
status on HRQoL, especially when there is a paradigm
shift from wasting and underweight to overweight and
obesity in HIV-infected people [38, 39]. Overweight and
obesity are rapidly growing threat to the health of gen-
eral population globally and nationally. This increases
the risks of developing cardiovascular and endocrine
complications and may have adverse effects on their
QoL [40]. In a cohort of HIV-infected people on ART,
almost half of the participants were reported to be either
overweight or obese [41] and increases the risk of devel-
oping comorbidities and impairment in HRQoL. Hence
constructing statistical models to include all the relevant
sociodemographic, behavioural, clinical, nutrition-related
factors and social support will facilitate better under-
standing of significant variables independently associated
with HRQoL in this era with advanced management fa-
cilities. Also, very little is known about the HRQoL of
people with HIV in Ireland. The aim of this study was to
assess the HRQoL of people with HIV attending the
GUIDE (genito-urinary medicine and infectious diseases)
clinic at St James’s hospital, Dublin, and its association
with the sociodemographic, behavioural, clinical, nutrition-
related factors and social support factors. The GUIDE clinic
is one of the 6 HIV specialist centres in Ireland, more than
half of outpatient attendees avail care from this clinic, and
the study sample characteristics are almost similar to that
of the national HIV cohort [42]. The conceptual framework
underpinning this study is based on the Wilson and
Cleary’s model of assessing health outcomes in terms
of biological and physiological variables, symptom sta-
tus, functional status, general health perception and
overall QoL and the causal relationship between these
variables [43].
Methods
Study design and settings
An observational cross-sectional study was conducted
between June 2010 and January 2012 to assess the
HRQoL of HIV-infected patients enrolled into the
Dublin HIV Cohort study from the GUIDE clinic. The
Dublin HIV Cohort study was established in 2006 for
5 years to enrol patients diagnosed with HIV at the three
HIV treatment centres in Dublin. A total of 1086 pa-
tients were enrolled into the Dublin HIV cohort study
from the GUIDE clinic, and 703 participants had one or
more follow up visits between June 2010 and January
2012. Of these 703 participants, 555 were approached by
one of the researchers and 528 patients consented for
the HRQoL assessment with a response rate of 95.1 %.
The remaining 148 potential participants were not
approached due to the limited number of researchers
recruiting participants and the busy clinical settings. Pa-
tients with certain physical and mental conditions
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disabling to complete the questionnaires independently
were excluded.
Data collection methods and measures
Potential participants were identified from the HIV clinic
list. They were systematically approached privately on
arrival, without disturbing the routines of this very busy
clinic. The study was explained to them using the study-
specific information leaflet and was given enough time
to make an independent decision. Consented partici-
pants were interviewed to collect sociodemographic
data, behaviour-related data and nutrition-related data
using a study-specific case report form (CRF). They then
completed three self-administered questionnaires: the
Medical Outcomes Study HIV (MOS-HIV) Health
Survey; the HIV/AIDS Targeted QoL questionnaire
(HAT-QoL) and the Medical Outcomes Study Social
Support Survey (MOS SSS) while waiting to be seen by
clinician and other healthcare team members. Participants
were given assistance to complete questionnaires when
needed. Completed questionnaires were briefly verified
when returned for any missing data and rechecked with
participants to make sure that the missing data were not
by chance. This method of data collection helped to re-
duce missing data and increased the item response rates.
Outcome variables
The HRQoL was assessed using the MOS-HIV Health
Survey which includes 35 closed-ended questions to as-
sess 10 dimensions of HRQoL [44]. Items were scored
on Likert scales and total score for each dimension
ranged from 0 to 100 with higher the score better the
QoL. The Physical Health Summary score (PHS) and
Mental Health Summary score (MHS) were derived
from the ten dimensions using the algorithm provided
in the manual. Using this questionnaire, the minimum
and maximum achievable scores are 0 and 100 with a
standardised mean score of 50 ± 10 standard deviation
for both PHS and MHS [44]. This method of data ana-
lysis helps to reduce the dimensionality and improve
measurement precision. The MOS-HIV Health Survey is
an extensively used and culturally adapted questionnaire
and demonstrated good reliability and validity in many
previous studies [21, 25, 44–47]. All the items in the
general health perception, pain, mental health and en-
ergy dimensions are similar to the generic questionnaire
SF-36, and hence facilitated comparisons with the avail-
able Irish general population QoL scores [48–50].
Predictor variables
The predictor variables including sociodemographic,
behavioural, clinical and nutrition-related variables and
perceived social support were collected using the
study-specific CRF, HAT-QoL questionnaire [51, 52],
Malnutrition Universal Screening Tool (MUST) [53]
and MOS SSS questionnaire [54]. These data were
based on the relevant information within the 1 year
period of the study.
Sociodemographic variables collected using the study-
specific CRF were age, gender, ethnicity, education,
employment and living condition. Education was
categorised as lower education (having no third-level
education) and higher education (having a third level
education). Based on the past 1 month, employment sta-
tus (employed or unemployed) was assessed to under-
stand their chances of having some meaningful day-to-
day interactions with people. They were considered as
employed if working part-time, full-time or involved in
any voluntary work. The living condition was categorised
as living alone or living with partner and/or with any
family members at the time of recruitment. Behavioural
variables including sexual activity status, illicit drugs use
and use of alcoholic drinks were assessed using the
study-specific CRF. Participants were considered as
sexually not active if they reported not being sexually ac-
tive for 1 year or more. Use of alcoholic drink was
assessed by asking if the participant had used any alco-
hol containing drink in the last year and were cate-
gorised as yes or no. Illicit drug use was assessed by
asking the participants about the use of any illicit drugs
in the past year and were categorised as yes or no.
Clinical variables included: the mode of HIV transmis-
sion categorised as men having sex with men (MSM) or
not MSM, time since HIV diagnosed, HIV-related symp-
toms perceived by the participants (yes or no), ART sta-
tus (yes or no), most recent CD4 level (≤350 cells/mm3
and >350 cells/mm3), most recent viral load (<40 copies/
ml and ≥ 40 copies/ml), HIV-associated complications
(yes or no) and co-morbidities (yes or no). Any medical
condition which could be associated with HIV infection
and was diagnosed after having HIV or its treatment was
considered as an HIV-associated complication and all
the others were considered as co-morbidities. HIV-
related symptoms were assessed by asking, “Have you
got any symptoms of HIV infection at present?” and
were asked to list down if they had any. Participants with
one or more symptoms matching with the 20-item HIV
symptom index were categorised as having symptoms of
HIV [55].
BMI, change in weight over 6 months and risk of mal-
nutrition were the variables included in the nutrition-
related factors and were assessed from participants and
their clinical records. Risk of malnutrition was assessed
using the MUST [53]. Malnutrition risk scores were cal-
culated based on the BMI, % of weight loss over a
6 month period and lack of any nutrition intake for
more than 5 days. Based on the total scores obtained,
malnutrition risks were assessed as low (total score = 0)
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or medium/high (total score ≥ 1) risks of malnutrition.
Social support-related factors included the perceived so-
cial support and disclosure worries. Perceived social sup-
port was assessed using the MOS SSS questionnaire.
This is a validated questionnaire and used in many pre-
vious studies involving people with HIV [21, 54, 56–58].
All the 19 items were scored on a Likert scale of 1 to 5
and an overall social support index was calculated, ran-
ging from 0 to 100, with higher score indicating better
availability of social support [54]. Disclosure worries
were assessed using the 3 items in the disclosure sub-
scale of the HAT-QoL questionnaire [51, 52]. This ques-
tionnaire was also validated and used in many previous
studies [26, 59–61]. A total disclosure score ranging
from 0 to 100 was calculated. A higher score indicated
less disclosure worries.
Statistical analysis
Data were analysed using the SPSS Software (PASW Sta-
tistics18). In univariate analysis χ2-test for categorical
data and Spearman’s correlation for continuous data
were performed to assess their association with HRQoL
scores. Comparisons of the median PHS and MHS
scores of the covariate groups were undertaken using
the Mann-Whitney U test. One sample t-test was used
to compare the mean scores with Irish normative values
for general health, pain, mental health, and energy di-
mensions. The PHS and MHS scores were dichotomised
as good and poor PHS and MHS groups respectively
based on the standardised mean score 50. Since logistic
regression analysis identifies the association of predictor
variables to a dichotomous outcome variable by control-
ling the effects of other predictor variables [62, 63] and
have been used in many previous studies [28, 31, 32, 47,
64, 65] this statistical test was used to identify potential
predictor variables independently associated with PHS
and MHS. Because there is no universal consensus in
choosing predictor variables in a multivariable logistic
regression analysis, we included all the variables with
p ≤ 0.2 in the univariate analysis and all clinically signifi-
cant variables regardless of their p-values, based on the
literature evidence [12, 16, 32]. Significance of the covar-
iates were assessed by the p-values (<0.05), odds ratios
(OR) and 95 % confidence intervals (CI) for association
between predictor variables and good HRQoL. The
Hosmer-Lemeshow goodness-of-fit statistic with p-value
above 0.05 was considered as a well-fitting regression
model, and percentage of the variability predicted by
model is explained by the Nagelkerke R2 [66].
Results
Descriptive characteristics of the study participants
A total of 528 people (75.1 % of the accessible popula-
tion) with HIV, aged 20 to 70 years, participated in this
study. Overall, 85.8 % were under 50 years of age and
135 (74.4 %) participants had HIV diagnosed 5 years
prior to the study. Participants were mostly males (69 %)
and Caucasians (73 %); more than half (54 %) were
employed; 38 % of the participants lived alone; and 48 %
had third level education. Almost 2/3rd of the partici-
pants (65 %) reported them being sexually active at the
time of the study. Within the 12 month period prior to
the study, a total of 80 (16 %) participants had used illicit
drugs and 398 (79 %) used alcoholic drinks. The major-
ity of participants were on ART (89 %), 441 (84 %) had
CD4 level above 350/mm3 and 391 (74 %) had viral load
of < 40 copies/ml. Very few participants (n = 86; 16 %)
reported of having symptoms of HIV. However, 275
(52.1 %) participants reported to have one or more co-
morbid conditions. A total of 281 (53.3 %) participants
were overweight or obese, and 60 (11.4 %) had medium
or high risk of malnutrition. The majority of participants
perceived very good level of social support with a me-
dian (IQR) score of 74.2 (49.3–95.3). However, disclos-
ure was a major concern and the median (IQR) score
was only 43.8 (25.0–62.5).
Health-related quality of life
A total of 521 participants completed the MOS-HIV
Health Survey questionnaire. The Cronbach’s alpha coef-
ficient calculated to determine the internal consistency
reliability of different HRQoL dimensions ranged from
0.83 to 0.91. The HRQoL of these participants in terms
of PHS, MHS and 10 dimensional scores are presented
in Table 1. The median (IQR) PHS and MHS scores
were 56.3 (46.8–60.3) and 50.8 (41.3–57.5) respectively.
Of the 10 subscales, the median values of energy/fatigue,
Table 1 HRQoL in patients with HIV: Summary scores and
Dimension scores
HRQoL scores Median (IQR) Mean (sd)
Summary Scores
Physical Health Summary Score 56.3 (46.8–60.3) 52.1 (11.0)
Mental Health Summary Score 50.8 (41.3–57.5) 48.6 (11.7)
Dimension scores
General Health perception 65.0 (45.0–85.0) 61.4 (26.5)
Physical Functioning 91.7 (66.7–100) 81.8 (25.0)
Role Functioning 100 (50.0–100) 79.3 (37.6)
Social Functioning 100 (80.0–100) 83.6 (27.0)
Cognitive Functioning 85.0 (60.0–95.0) 75.2 (24.9)
Pain 88.9 (55.6–100) 76.7 (25.7)
Mental Health 72.0 (52.0–84.0) 68.0 (22.0)
Energy/Fatigue 60.0 (45.0–80.0) 60.6 (23.3)
Health Distress 80.0 (60.0–95.0) 71.9 (27.4)
Quality of Life 75.0 (50.0–75.0) 68.0 (23.2)
Abbreviations: IQR: inter quartile range, sd standard deviation
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general health perception, mental health and quality of
life dimensions scores were 75 or below, and were lower
than the other dimensions. There was a significantly
strong correlation between PHS and MHS (Spearman’s
correlation = 0.66; p < 0.001). MHS was lower than PHS
in all the covariate categories, and majority of these cat-
egories had median score lower than the standardised
mean score of 50 (Table 2). Since there is no universal
consensus on categorisation of continuous data for stat-
istical analysis [67] and the cut-off points used in previ-
ous studies were either 25th percentile [28, 32, 47], mean
[64] or median [68, 69], the participants in this study
were categorised as having good and poor PHS/MHS
scores based on the standardised mean score, 50 [44].
Overall, there were 363 (68.8 %) with good PHS and 274
(51.9 %) participants with good MHS.
Using the one-sample t-test, the total scores for the
comparable dimensions of this study were compared
with the existing Irish normative values for general
population [50]. HIV participants’ scores were signifi-
cantly lower for the general health perception (61.4 vs
73.8, p < 0. 001, 95 % CI: −14.7 to −10.2), mental health
(67.9 vs 64.8, p < 0.001, 95 % CI: −11.7 to −7.9) and en-
ergy (60.6 vs 64.8, p < 0.001, 95 % CI: −6.3 to −2.2).
There was no significant difference in the pain scores.
The median PHS and MHS scores of the covariate cat-
egories were compared and presented in Table 2. The
PHS and MHS scores were significantly higher in partic-
ipants who: had higher education (p < 0.001), were
employed (p < 0.001), were sexually active (p < 0.001),
not currently using illicit drugs (p = 0.001), did not have
symptoms of HIV (p < 0.001), had CD4 level > 350cells/
mm3 (p < 0.005), did not have HIV complications (p <
0.01), did not have co-morbidities (p < 0.001), and had
low risk of malnutrition (p < 0.005). Significantly higher
MHS score was reported by male participants (p =
0.007) and participants with a recent viral load < 40
copies/ml (p = 0.008). Perceived social support was
moderately correlated with PHS and MHS scores (p <
0.001) and time since HIV diagnosed had a weak cor-
relation with PHS score (p = 0.002), but not with MHS
(Table 2). However, there was no correlation between
disclosure worries and HRQoL score.
The association of the predictor variables with the
PHS and MHS categories were explored using univariate
analysis and multivariable logistic regression analyses
(enter method) and are presented in Tables 3 and 4. The
variables significantly associated with both PHS and
MHS scores in the multivariable models were symptoms
of HIV, comorbidities, employment, ethnicity and social
support (Table 3). Male gender, higher education, not
using alcoholic drinks and not having HIV-associated
complications were associated with good PHS, whereas
age, no current use of illicit drugs, BMI and low risk of
malnutrition were associated with MHS. Many variables
significantly associated with PHS and MHS in the uni-
variate analyses were not significant in the multivariable
models (Table 4). The Hosmer-Lemeshow goodness-of-
fit test p-values were 0.402 and 0.349 for the PHS and
MHS models constructed respectively suggestive of well-
fitting models. It is assumed that 47 % of the variability
in the PHS (Nagelkerke R2 = 0.47) and 38 % of the vari-
ability in the MHS (Nagelkerke R2 = 0.38) is explained
by these models.
Discussion
Overall, the HRQoL of the patients with HIV in this co-
hort were within the average level. This was a group of
HIV-infected people availing of advanced HIV manage-
ment, with good immune function, viral suppression and
majority were under 50 years of age. Hence, their func-
tioning, well-being and overall HRQoL could be ex-
pected to be almost similar to the general population.
However, this cohort had lower scores on their general
health perception, energy and mental health, compared
to the general population in Ireland [50] indicating that
HIV-infected peoples’ physical and mental health func-
tioning and well-being are still impaired, though there is
significant improvement in mortality and morbidity [1,
2]. On the other hand, participants in this study reported
better HRQoL compared to a small previous Irish study
in late 1990s using the MOS-HIV Health survey [11].
Currently, people are diagnosed in early stages of HIV,
treated with ART before their immune functions deteri-
orate and thus are spared many HIV-associated compli-
cations. As a result, the impact of this illness on their
physical health and functioning is substantially lower
than a decade ago. In that study, the participants
reported lowest score of 38 for the health distress di-
mension, indicating that they were discouraged and
frightened by HIV. A notable reduction in health distress
in our study may be related to the transformation of this
once lethal condition to a treatable illness, and lessened
the uncertainty about life and anxiety about future.
Having symptoms of HIV, complications and co-
morbidities were the most significant clinical variables
independently associated with HRQoL. The relapsing
and remitting nature of HIV illness could affect
functionality and life satisfaction leading to impaired
QoL. Symptoms of HIV have been reported as being
associated with HRQoL in many previous studies also
[16, 27, 28, 30, 31, 70, 71]. The most common symptoms
reported by the participants in our study were sleep
disturbances, lack of energy, abdominal discomfort,
lipodystrophy and depression. All these may be due
to the unfavourable effects of HIV-associated stigma,
discrimination, disclosure and other psychosocial is-
sues. Disclosure was substantially a major concern
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Table 2 HRQoL in HIV: Covariate categories and comparisons of PHS and MHS median scores
n (%) PHS: Median (IQR) p MHS: Median (IQR) p
Age (years)a 521 (98.7) −0.065a 0.139 0.061a 0.165
Gender 521 (98.7) – 0.171 – 0.007
Male 361 (69.3) 56.6 (48.–60.5) – 51.9 (42.7–57.8) –
Female 160 (30.7) 55.3 (42.9–60.1) – 47.2 (36.8–56.4) –
Ethnicity 521 (98.7) – <0.001 – 0.025
Caucasian 379 (72.7) 55.5 (44.5–60.1) – 50.5 (39.3–57.0) –
Non-Caucasian 142 (27.3) 58.1 (53.0–61.0) – 51.6 (45.7–58.5) –
Education 517 (97.9) – <0.001 – <0.001
Higher education 247 (47.6) 58.5 (53.1–61.0) – 53.0 (45.7–58.9) –
Lower education 272 (52.4) 53.0 (41.5–59.1) – 48.3 (36.7–56.0) –
Employment 518 (98.1) – <0.001 – <0.001
Employed 282 (54.4) 58.9 (53.7–61.3) – 54.6 (46.3–60.0) –
Unemployed 236 (45.6) 50.2 (37.3–58.1) – 46.1 (35.5–54.2) –
Living condition 521 (98.7) – 0.705 – 0.615
Lives with family 323 (62.0) 56.1 (48.1–60.2) – 53.1 (45.1–58.8) –
Lives alone 198 (38.0) 56.5 (46.2–60.5) – 49.2 (39.1–56.4) –
Sexual activity status 495 (93.8) – <0.001 – <0.001
Sexually active 322 (65.1) 57.5 (50.4–60.8) – 53.0 (44.1–58.6) –
Sexually not active 173 (34.9) 52.5 (37.8–59.2) – 47.5 (36.4–54.9) –
Current use of illicit drugs 494 (93.6) – 0.001 – <0.001
No 415 (84.0) 56.7 (49.0–60.6) – 51.9 (42.9–57.6) –
Yes 79 (16.0) 52.3 (38.3–59.0) – 44.4 (35.7–55.3) –
Use of alcoholic drinks 494 (93.6) – 0.017 – 0.007
No 99 (20.0) 53.6 (38.0–59.6) – 47.7 (34.6–55.5) –
Yes 395 (80.0 56.8 (48.8–60.4) – 52.2 (42.3–57.6) –
HIV transmission mode 521 (98.7) – 0.001 – 0.002
MSM 177 (34.0) 58.1 (50.7–61.0) – 53.2 (45.3–58.9) –
Not MSM 344 (66.0) 55.4 (44.7–60.1) – 49.3 (39.1–56.9) –
Time since HIV diagnoseda 521 (98.7) −0.134a 0.002 −0.013a 0.774
HIV symptoms 521 (98.7) – <0.001 – <0.001
Yes 85 (16.3) 44.7 (32.1–54.5) – 36.1 (28.6–48.4) –
No 436 (83.7) 57.5 (50.3–60.8) – 52.6 (44.8–58.5) –
Current ART status 521 (98.7) – 0.096 – 0.168
Yes 436 (88.9) 56.1 (46.6–60.3) – 50.6 (40.9–57.5) –
No 58 (11.1) 57.6 (52.6–60.7) – 53.8 (44.3–58.1) –
Recent CD4 level 521 (98.7) – 0.003 – <0.001
≤ 350cells/mm3 87 (16.7) 51.7 (37.6–59.6) – 46.3 (36.0–53.9) –
> 350cells/mm3 434 (83.3) 56.7 (48.9–60.4) – 51.8 (42.3–57.9) –
Recent viral load 521 (98.7) – 0.112 – 0.008
< 40 copies/ml 413 (79.3) 56.5 (48.8–60.4) – 51.2 (42.6–57.9) –
≥ 40 copies/ml 108 (20.7) 55.2 (42.9–60.1) – 47.9 (35.0–55.8) –
HIV complications 521 (98.7) – <0.001 – 0.006
No 441 (84.6) 57.0 (49.2–60.7) – 51.4 (42.4–57.7) –
Yes 80 (15.4) 49.2 (36.6–56.6) – 47.5 (35.0–55.1) –
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for majority of the participants irrespective of the
duration of being diagnosed with HIV. Providing
training programs such as Yoga, Meditation, Mind-
fulness and Counselling to reduce emotional stress
and to improve mental health, psychological func-
tioning and well-being may help them to manage
these issues [72–75]. According to Creswell et al.
mindfulness meditation trainings improved HIV-infected
patients’ adherence to medication and buffered the im-
mune function [75].
As evident in the literature, participants with good so-
cial support had better HRQoL compared to their coun-
terparts [21, 47, 58, 76, 77]. Like any other chronic
illness, these patients also need someone to care for
their physical, psychological and social needs. However,
the fear of discrimination and rejection by family
Table 2 HRQoL in HIV: Covariate categories and comparisons of PHS and MHS median scores (Continued)
Co-morbidities 521 (98.7) – <0.001 – <0.001
Yes 271 (52.0) 51.7 (38.5–58.8) – 47.1 (35.7–55.0) –
No 250 (48.0) 58.9 (54.2–61.1) – 54.5 (46.3–59.7) –
BMI (kg/m2)a 520 (98.5) −0.003a 0.948 0.022a 0.622
Risk of malnutrition 517 (97.3) – 0.001 – 0.004
Low risk 457 (88.4) 56.6 (49.1–60.4) – 51.5 (42.4–57.6) –
High risk 60 (11.6) 47.8 (35.9–58.8) – 45.3 (33.7–55.5) –
Overall Social Supporta 509 (96.4) 0.299a <0.001 0.386a <0.001
Disclosure issuesa 490 (92.8) 0.062a 0.182 0.026a 0.561
Abbreviations: PHS physical health summary score, MHS mental health summary score, IQR inter quartile range
aSpearman’s correlation
Table 3 HRQoL in HIV patients: Multivariable Logistic Regression Models for PHS and MHS
Good PHS Good MHS
Variables OR (95 % CI) p OR (95 % CI) P
Age (Years) 1.00 (0.97–1.03) 0.919 1.05 (1.02–1.08) 0.001
Gender (Male) 2.47 (1.22–4.98) 0.012 1.76 (0.96–3.24) 0.068
Ethnicity (Non-Caucasian) 3.55 (1.63–7.73) 0.001 2.11 (1.12–3.99) 0.021
Education (Higher education) 2.33 (1.32–4.12) 0.004 1.10 (0.68–1.80) 0.697
Employment (Employed) 4.02 (2.27–7.14) <0.001 2.12 (1.28–3.50) 0.003
Living condition (Lives with family) 0.81 (0.45–1.47) 0.491 0.70 (0.42–1.16) 0.166
Sexually active (Yes) 1.22 (0.70–2.11) 0.478 1.04 (0.63–1.71) 0.881
Current use of illicit drugs (No) 1.55 (0.76–3.16) 0.224 2.53 (1.31–4.89) 0.006
Current use of alcoholic drinks (No) 2.00 (1.01–3.98) 0.047 0.69 (0.39–1.25) 0.223
MSM (Yes) 0.95 (0.47–1.92) 0.890 0.69 (0.38–1.26) 0.227
Time since HIV diagnosed (Years) 1.01 (0.97–1.06) 0.579 1.03 (0.98–1.07) 0.258
Symptoms of HIV (Yes) 3.49 (1.77–6.89) <0.001 3.56 (1.79–7.10) <0.001
On ART (Yes) 3.11 (0.96–10.11) 0.059 2.47 (0.95–6.42) 0.063
CD4 count (>350 cells/mm3) 1.22 (0.63–2.39) 0.558 1.54 (0.83–2.86) 0.170
Viral load (<40 copies/ml) 1.65 (0.72–3.79) 0.240 1.73 (0.81–3.72) 0.158
HIV-associated complications (No) 1.97 (1.01–3.82) 0.046 1.13 (0.60–2.12) 0.708
Co-morbid conditions (No) 2.29 (1.29–4.07) 0.004 2.46 (1.50–4.02) <0.001
BMI (Kg/m2) 0.97 (0.90–1.03) 0.283 0.92 (0.86–0.97) 0.004
Malnutrition risk (Low) 1.73 (0.75–3.97) 0.198 2.25 (1.02–4.97) 0.045
Social support (Total score 0–100) 1.03 (1.02–1.04) <0.001 1.03 (1.02–1.04) <0.001
Disclosure worries (Total score 0–100) 1.00 (0.99–1.01) 0.608 1.01 (1.00–1.02) 0.105
Good PHS: PHS score > 50; Good MHS: MHS score >50
Abbreviations: OR odds ratio, CI confidence interval
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Table 4 Univariate analysis and Multivariable logistic regression analysis models for PHS and MHS
Good PHS (Total PHS score > 50) Good MHS (Total MHS score > 50)
Univariate analysis Multivariable analysis Univariate analysis Multivariable analysis
Variables OR (95 % CI) p OR (95 % CI) p OR (95 % CI) p OR (95 % CI) p
Age (years) 0.984 (0.96–1.01) 0.13 1.00 (0.97–1.03) 0.919 1.024 (1.00–1.05) 0.017 1.05 (1.02–1.08) 0.001
Gender
Male 1.546 (1.04–2.30) 0.031 2.47 (1.22–4.98) 0.012 1.611 (1.11–2.34) 0.013 1.76 (0.96–3.24) 0.068
Female (Ref) – – – – – – – –
Ethnicity
Non-Caucasian 2.53 (1.57–4.09) <0.001 3.55 (1.63–7.73) 0.001 1.23 (0.84–1.81) 0.295 2.11 (1.12–3.99) 0.021
Caucasian (Ref) – – – – – – – –
Education
Higher education 3.581 (2.37–5.40) <0.001 2.33 (1.32–4.12) 0.004 1.75 (1.23–2.48) 0.002 1.10 (0.68–1.80) 0.697
Lower education (Ref) – – – – – – – –
Employment
Employed 5.524 (3.65–8.43) <0.001 4.02 (2.27–7.14) <0.001 3.327 (2.32–4.78) <0.001 2.12 (1.28–3.50) 0.003
Unemployed (Ref) – – – – – – – –
Living condition
Lives with family 1.037 (0.71–1.52) 0.851 0.81 (0.45–1.47) 0.491 1.038 (0.73–1.48) 0.838 0.70 (0.42–1.16) 0.166
Lives alone (Ref) – – – – – – – –
Sexual activity status
Sexually active 2.626 (1.77–3.91) <0.001 1.22 (0.70–2.11) 0.478 1.768 (1.22–2.57) 0.003 1.04 (0.63–1.71) 0.881
Sexually not active (Ref) – – – – – – – –
Current use of illicit drugs
No 2.237 (1.37–3.66) 0.001 1.55 (0.76–3.16) 0.224 2.229 (1.36–3.66) 0.002 2.53 (1.31–4.89) 0.006
Yes (Ref) – – – – – – – –
Use of alcoholic drinks
No 0.742 (0.47–1.18) 0.209 2.00 (1.01–3.98) 0.047 0.496 (1.36–3.66) 0.002 0.69 (0.39–1.25) 0.223
Yes (Ref) – – – – – – – –
HIV transmission mode
MSM 1.96 (1.29–2.99) 0.002 0.95 (0.47–1.92) 0.89 1.678 (1.16–2.43) 0.006 0.69 (0.38–1.26) 0.227
Not MSM (Ref) – – – – – – – –
Time since HIV diagnosed 0.956 (0.93–0.99) 0.004 1.01 (0.97–1.06) 0.579 1 (0.97–1.03) 0.987 1.03 (0.98–1.07) 0.258
HIV symptoms
No 5.221 (3.20–8.53) <0.001 3.49 (1.77–6.89) <0.001 5.294 (3.042–9.21) <0.001 3.56 (1.79–7.10) <0.001
Yes (Ref) – – – – – – – –
Current ART status
No 1.578 (.83–3.02) 0.167 3.11 (0.96–10.11) 0.059 1.316 (0.76–2.29) 0.33 2.47 (0.95–6.42) 0.063
Yes (Ref) – – – – – – – –
Recent CD4 level
> 350cells/mm3 2.029 (1.26–3.26) 0.003 1.22 (0.63–2.39) 0.558 2.166 (1.35–3.48) 0.001 1.54 (0.83–2.86) 0.17
≤ 350cells/mm3 (Ref) – – – – – – – –
Recent viral load
< 40 copies/ml 1.471 (0.94–2.30) 0.089 1.65 (0.72–3.79) 0.24 1.511 (0.99–2.31) 0.058 1.73 (0.81–3.72) 0.158
≥ 40 copies/ml (Ref) – – – – – – – –
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members, relatives and friends prevent them from dis-
closing their HIV status resulting in mental conflicts and
isolation. This may reduce the number of people they
can rely on to share and discuss their anxieties and con-
cerns. Some people are even reluctant to seek employ-
ment because of the worry of disclosing to their HIV
status to employer and co-workers.
The association of BMI and malnutrition with MHS as
a risk factor suggests that increase in BMI may lead to
impairment in HRQoL. When explored further, the me-
dian MHS was lower in the underweight (BMI < 18.5 kg/
m2) and obese (BMI ≥ 30 kg/m2) groups compared to
the normal weight (BMI 18.5 to < 25 kg/m2) and over-
weight (BMI ≥ 25 kg/m2 to < 30 kg/m2) groups. Obesity
may be due to the lack of physical activities and poor
lifestyle behaviours. This may lead to mental health is-
sues including depression as reported by Harrington et
al. in the overweight and obese group based on the
SLÁN study in general Irish population [78]. They re-
ported that obese participants were less likely to engage
in healthy lifestyle behaviours and had higher chances of
depression. Another reason could be the anxiety and
worries related to the body disfigurations and the abnor-
mal fat distribution as reported by Verolet et al. in a
recent study [79].
The association of employment and HRQoL were
already reported in many previous studies [16, 22, 31,
65, 80]. In general, unemployment has an adverse effect
on psychological well-being and QoL of an individual
due to the feeling of worthlessness, loneliness, financial
limitations and poor standard of living. On the other
hand, people with HIV may be reluctant to go back to
wok or seek new job because of the stress and miscon-
ceptions related to disclosure of their HIV status to their
employers and colleagues. However, it was not clear
whether the unemployment in our study was due to
HIV infection as no further data related to their un-
employment were collected. Future studies to explore
the reasons for unemployment in HIV-infected people
are warranted to plan programmes to support them to
get jobs, engage in voluntary activities and other inter-
ventions to improve their HRQoL.
Our findings show that the non-Caucasians have bet-
ter HRQoL compared to their Caucasian counterparts.
HRQoL is a subjective construct and is influenced by
different factors of human life directly or indirectly
related to health. In our study more than 90 % of the
non-Caucasians were from SSA countries and the major-
ity of them migrated to Ireland during the Celtic tiger
period. Better healthcare services compared to their
home countries [81] and the well-established social
welfare system in Ireland may have helped them to have
a high level HRQoL.
Age was a protector of good MHS, and was not associ-
ated with PHS. Participants in this study were mostly
under 50 years of age and the chances of impairments in
their physical functioning due to ageing are less. As
people with chronic illnesses live longer, they learn to
cope and adjust with the illness, especially when their
physical functioning is less affected. Since majority of
the older participants had HIV infection for more than
10 years, their ability to cope and adjust with this illness
will be better than their younger counterparts. Another
factor is that the older participants have more life expe-
riences and thus higher tolerance of the stresses of life
by acquiring effective stress management skills, espe-
cially when living with a chronic illness like HIV.
The most important limitation is the cross-sectional
nature of this study. Hence the exact direction of the as-
sociations between predictor variables and HRQoL can-
not be established. A follow-up study in near future will
be of beneficial to explore and better understand the
Table 4 Univariate analysis and Multivariable logistic regression analysis models for PHS and MHS (Continued)
HIV complications
No 3.097 (1.90–5.04) <0.001 1.97 (1.01–3.82) 0.046 1.615 (1.00–2.61) 0.051 1.13 (0.60–2.12) 0.708
Yes (Ref) – – – – – – – –
Co-morbidities
No 3.873 (2.57–5.85) <0.001 2.29 (1.29–4.07) 0.004 2.529 (1.78–3.60) <0.001 2.46 (1.50–4.02) <0.001
Yes (Ref) – – – – – – – –
BMI (kg/m2) 1.014 (0.97–1.06) 0.533 0.97 (0.90–1.03) 0.283 0.982 (0.95–1.02) 0.369 0.92 (0.86–0.97) 0.004
Risk of malnutrition
Low risk 3.069 (1.78–5.31) <0.001 1.73 (0.75–3.97) 0.198 2.48 (1.41–4.38) 0.002 2.25 (1.02–4.97) 0.045
High risk (Ref) – – – – – – – –
Overall Social Support 1.022 (.02–1.03) <0.001 1.03 (1.02–1.04) <0.001 1.025 (1.02–1.03) <0.001 1.03 (1.02–1.04) <0.001
Disclosure issues 0.996 (0.99–1.00) 0.321 1.00 (0.99–1.01) 0.608 1.002 (1.00–1.01) 0.577 1.01 (1.00–1.02) 0.105
Abbreviations: OR odds ratio, CI confidence interval, PHS physical health summary score, MHS mental health summary score
The bolded p-values correspond to the variables that are significant in both the univariate and multivariable analyses
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associations. Recruitment of participants from the out-
patient clinics and thereby excluding hospitalised pa-
tients and those who cannot or were not attending
outpatient clinics is another limitation of this study. This
may have even contributed to the high ceiling effects on
the role functioning and social functioning dimensions
of HRQoL. Nevertheless, statistically controlling the
confounding effects of more than twenty factors related
to HIV-infected people’s lives and the percentages of
HRQoL variabilities explained by the two statistical
models are strengths of this study. To our knowledge, in
Ireland, this is the first study with large sample size and
complexity to assess the HRQoL of people with HIV.
Conclusions
There is still impairment in the HRQoL of people with
HIV in this era with advanced management facilities.
The routinely assessed CD4 count and viral load do not
reflect the effects of HIV on their HRQoL. Hence, regu-
lar assessment of HRQoL using reliable methods will
help to better understand the effects of HIV and its
treatment on people’s lives and to facilitate a holistic
management of this chronic illness. Alleviating symp-
toms of HIV and preventing comorbid conditions and
obesity are important in managing HIV. Providing psy-
chosocial support to return to work or exploring new
opportunities will help to improve HRQoL.
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